These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 24584620)

  • 1. 32 years' experience of peritoneal dialysis-related peritonitis in a university hospital.
    van Esch S; Krediet RT; Struijk DG
    Perit Dial Int; 2014; 34(2):162-70. PubMed ID: 24584620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exit-Site Dressing and Infection in Peritoneal Dialysis: A Randomized Controlled Pilot Trial.
    Mushahar L; Mei LW; Yusuf WS; Sivathasan S; Kamaruddin N; Idzham NJ
    Perit Dial Int; 2016; 36(2):135-9. PubMed ID: 26374836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of peritoneal dialysis catheter infections in Saudi peritoneal dialysis patients: the emergence of high-level mupirocin resistance.
    Al-Hwiesh AK; Abdul-Rahman IS; Al-Muhanna FA; Al-Sulaiman MH; Al-Jondebi MS; Divino-Filho JC
    Int J Artif Organs; 2013 Jul; 36(7):473-83. PubMed ID: 23897229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Topical Chlorhexidine and Mupirocin for the Prevention of Exit-Site Infection in Incident Peritoneal Dialysis Patients.
    Htay H; Johnson DW; Wu SY; Oei EL; Foo MWY; Choo JCJ
    Perit Dial Int; 2017; 37(3):266-272. PubMed ID: 28183858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Factors for and Outcomes of Catheter-Associated Peritonitis in Children: The SCOPE Collaborative.
    Sethna CB; Bryant K; Munshi R; Warady BA; Richardson T; Lawlor J; Newland JG; Neu A;
    Clin J Am Soc Nephrol; 2016 Sep; 11(9):1590-1596. PubMed ID: 27340282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Effectiveness of Local Application of Chlorhexidine Gluconate, Mupirocin Ointment, and Normal Saline for the Prevention of Peritoneal Dialysis-related Infections (COSMO-PD Trial): a multicenter randomized, double-blind, controlled protocol.
    Nochaiwong S; Ruengorn C; Noppakun K; Panyathong S; Dandecha P; Sood MM; Saenjum C; Awiphan R; Sirilun S; Mongkhon P; Chongruksut W; Thavorn K;
    Trials; 2019 Dec; 20(1):754. PubMed ID: 31856900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternating Mupirocin/Gentamicin is Associated with Increased Risk of Fungal Peritonitis as Compared with Gentamicin Alone - Results of a Randomized Open-Label Controlled Trial.
    Wong PN; Tong GM; Wong YY; Lo KY; Chan SF; Lo MW; Lo KC; Ho LY; Tse CW; Mak SK; Wong AK
    Perit Dial Int; 2016; 36(3):340-6. PubMed ID: 27044796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Exit-Site Gentamicin Prophylaxis and Gentamicin Resistance in a Peritoneal Dialysis Program.
    Chen SS; Sheth H; Piraino B; Bender F
    Perit Dial Int; 2016; 36(4):387-9. PubMed ID: 26634567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of gentamicin and mupirocin in the prevention of exit-site infection and peritonitis in peritoneal dialysis.
    Mahaldar A; Weisz M; Kathuria P
    Adv Perit Dial; 2009; 25():56-9. PubMed ID: 19886318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Center Effects and Peritoneal Dialysis Peritonitis Outcomes: Analysis of a National Registry.
    Htay H; Cho Y; Pascoe EM; Darssan D; Nadeau-Fredette AC; Hawley C; Clayton PA; Borlace M; Badve SV; Sud K; Boudville N; McDonald SP; Johnson DW
    Am J Kidney Dis; 2018 Jun; 71(6):814-821. PubMed ID: 29289475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome and complications in peritoneal dialysis patients: a five-year single center experience.
    Alwakeel JS; Alsuwaida A; Askar A; Memon N; Usama S; Alghonaim M; Feraz NA; Shah IH; Wilson H
    Saudi J Kidney Dis Transpl; 2011 Mar; 22(2):245-51. PubMed ID: 21422621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effect of Exit-Site Antibacterial Honey Versus Nasal Mupirocin Prophylaxis on the Microbiology and Outcomes of Peritoneal Dialysis-Associated Peritonitis and Exit-Site Infections: A Sub-Study of the Honeypot Trial.
    Zhang L; Badve SV; Pascoe EM; Beller E; Cass A; Clark C; de Zoysa J; Isbel NM; McTaggart S; Morrish AT; Playford EG; Scaria A; Snelling P; Vergara LA; Hawley CM; Johnson DW;
    Perit Dial Int; 2015 Dec; 35(7):712-21. PubMed ID: 26224790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peritonitis in children with automated peritoneal dialysis: a single-center study of a 10-year experience.
    Dotis J; Myserlis P; Printza N; Stabouli S; Gkogka C; Pavlaki A; Papachristou F
    Ren Fail; 2016 Aug; 38(7):1031-5. PubMed ID: 27185324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of peritoneal dialysis-related peritonitis with ciprofloxacin monotherapy: clinical outcomes and bacterial susceptibility over two decades.
    Fontán MP; Cambre HD; Rodríguez-Carmona A; Muñiz AL; Falcón TG
    Perit Dial Int; 2009; 29(3):310-8. PubMed ID: 19458304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The changing trends of peritoneal dialysis related peritonitis and novel risk factors.
    Ozisik L; Ozdemir FN; Tanriover MD
    Ren Fail; 2015 Jul; 37(6):1027-32. PubMed ID: 26042343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients.
    Bernardini J; Bender F; Florio T; Sloand J; Palmmontalbano L; Fried L; Piraino B
    J Am Soc Nephrol; 2005 Feb; 16(2):539-45. PubMed ID: 15625071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catheter revision for the treatment of intractable exit site infection/tunnel infection in peritoneal dialysis patients: a single centre experience.
    Cho KH; DO JY; Park JW; Yoon KW
    Nephrology (Carlton); 2012 Nov; 17(8):760-6. PubMed ID: 22804821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbial spectrum and outcome of peritoneal dialysis related peritonitis in Qatar.
    Shigidi MM; Fituri OM; Chandy SK; Asim M; Al Malki HA; Rashed AH
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):168-73. PubMed ID: 20061719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decrease in Staphylococcus aureus exit-site infections and peritonitis in CAPD patients by local application of mupirocin ointment at the catheter exit site.
    Thodis E; Bhaskaran S; Pasadakis P; Bargman JM; Vas SI; Oreopoulos DG
    Perit Dial Int; 1998; 18(3):261-70. PubMed ID: 9663889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peritonitis remains the major clinical complication of peritoneal dialysis: the London, UK, peritonitis audit 2002-2003.
    Davenport A
    Perit Dial Int; 2009; 29(3):297-302. PubMed ID: 19458302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.